Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer
Open Access
- 17 February 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (6) , 3887-3903
Abstract
Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancerKeywords
This publication has 63 references indexed in Scilit:
- Hedgehog Signaling in Prostate Cancer and Its Therapeutic ImplicationInternational Journal of Molecular Sciences, 2013
- NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128Oncogenesis, 2013
- β4 Integrin signaling induces expansion of prostate tumor progenitorsJournal of Clinical Investigation, 2013
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell CarcinomaNew England Journal of Medicine, 2012
- Frequent Deregulations in the Hedgehog Signaling Network and Cross-Talks with the Epidermal Growth Factor Receptor Pathway Involved in Cancer Progression and Targeted TherapiesPharmacological Reviews, 2010
- Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cellsMolecular Cancer, 2010
- Cytotoxic Effects Induced by Docetaxel, Gefitinib, and Cyclopamine on Side Population and Nonside Population Cell Fractions from Human Invasive Prostate Cancer CellsMolecular Cancer Therapeutics, 2010
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell CarcinomaNew England Journal of Medicine, 2009
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449New England Journal of Medicine, 2009
- Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signallingCancer Cell International, 2008